$23.66
-0.10 (-0.42%)
Performance
1D
—
1W
—
1M
—
3M
-9.42%
6M
+346.42%
1Y
+350.67%
YTD
+164.21%
Open$23.95
Previous Close$23.76
Day High$24.36
Day Low$23.44
52W High$30.60
52W Low$2.76
Volume—
Avg Volume967.6K
Market Cap3.02B
P/E Ratio—
EPS$-3.00
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$19.51
Above
SMA 200
$8.26
Above
RSI (14)
60.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
17 analysts
Price Target
+3.6% upside
Current
$23.66
$23.66
Target
$24.51
$24.51
$15.34
$24.51 avg
$36.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 36.12M | 878.33M | 917.39M |
| Net Income | -365,532,027 | 120.27M | 166.79M |
| Profit Margin | -1,011.8% | 13.7% | 18.2% |
| EBITDA | -394,451,670 | 272.46M | 241.94M |
| Free Cash Flow | — | 126.96M | 147.40M |
| Rev Growth | — | +6.0% | +16.1% |
| Debt/Equity | — | 0.25 | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |